Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
25 pending office actions • 17 art units • 24 examiners • 0 of 25 (0%) have an AI response strategy ready • 10 patents granted in the last 365 days
Thomas Jefferson University maintains an active prosecution presence with 25 pending office actions in the Biotechnology & Pharmaceuticals technology area. These active matters are distributed among 25 distinct examiners, showing a high degree of diversification in the personnel reviewing the university's applications. This distribution suggests that the university's patent strategy involves a broad array of researchers and legal representatives interacting with many different officials.
The portfolio spans 16 distinct art units, which indicates that the university's research and patenting efforts cover a wide range of specialized sub-disciplines within the broader biotechnology sector. This breadth of coverage requires navigating various administrative groups within the patent office simultaneously to maintain progress across the entire portfolio. Each of these units may have its own specific procedural expectations and timelines that the university must manage.
Despite the current volume of active matters, the workload is evenly spread, as the busiest examiner, SWITZER, JULIET CAROLINE, is responsible for only 1 pending office action. This lack of concentration suggests that no examiner has a dominant influence over the university's current patent outcomes. Such a decentralized structure can help mitigate the risk associated with the specific examination tendencies of any individual reviewer.
Based on the USPTO statutory response window for each pending office action. 8 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 8 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 6 (24%) |
| §103 only | 4 (16%) |
| §102 only | 1 (4%) |
| §112 only | 2 (8%) |
| Double-patenting only | 1 (4%) |
| Double-patenting + other | 2 (8%) |
| Multi-statute (no §101) | 9 (36%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LU, CHENG | 2 | 54.1% | +64.1% |
| SWITZER, JULIET CAROLINE | 1 | 42.4% | +54.0% |
| CHORBAJI, MONZER R | 1 | 76.4% | +21.3% |
| BALAJI, KAVYA SHOBANA | 1 | 20.0% | +63.5% |
| SANZ, GABRIEL A | 1 | 61.8% | +37.4% |
| FERNANDEZ, KATHERINE L | 1 | 58.0% | +37.9% |
| LEE, ANDREW P | 1 | 48.3% | +23.1% |
| FRITH, SEAN A | 1 | 62.5% | +26.7% |
| DEKARSKE, MADELINE MCGUIRE | 1 | 0.0% | +0.0% |
| CHUKWURAH, NATHANIEL C | 1 | 84.8% | +11.0% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18593283 | ANGLE-ADJUSTABLE RATCHET TOOL | CHUKWURAH, NATHANIEL C | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17378274 | HUMAN MIRNAS FOR USE IN DIAGNOSIS, PROGNOSIS, AND THERAPY OF HUMAN CONDITIONS AND DISEASES | DACE DENITO, ALEXANDRA GERALDINE | 84d overdue |
| 18510470 | CORTICAL RECORDING AND SIGNAL PROCESSING METHODS AND DEVICES | OGLES, MATTHEW ERIC | 74d overdue |
| 18745131 | SYSTEM AND METHOD FOR BREAST CANCER DETECTION USING CO-LOCALIZED ULTRASOUND-MAMMOGRAPHY | FERNANDEZ, KATHERINE L | 14d |
| 18065736 | MEASURING FREQUENCY OF PATHOGEN-SPECIFIC T CELLS IN PERIPHERAL BLOOD | GAO, ASHLEY HARTMAN | 22d |
| 18034720 | GENE SHUFFLED LYSSAVIRUS VACCINE | CHEN, STACY BROWN | 61d |
| 18982106 | COMPOSITIONS AND METHODS OF USING HisGTG TRANSFER RNAS (tRNAs) | SWITZER, JULIET CAROLINE | — |
| 18853928 | SYSTEMS AND METHODS FOR CONDUCTING REMOTE NEURO-OPHTHALMIC EXAMINATIONS ON A MOBILE DEVICE | BALAJI, KAVYA SHOBANA | — |
| 18655854 | COMPOSITION AND METHOD FOR MUSCLE REPAIR AND REGENERATION | LEE, ANDREW P | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18706936 | SYSTEMS, DEVICES, AND ASSOCIATED METHODS FOR THERAPEUTIC EUS ANCHOR | FRITH, SEAN A | 49d overdue |
| 18745131 | SYSTEM AND METHOD FOR BREAST CANCER DETECTION USING CO-LOCALIZED ULTRASOUND-MAMMOGRAPHY | FERNANDEZ, KATHERINE L | 14d |
| 18982106 | COMPOSITIONS AND METHODS OF USING HisGTG TRANSFER RNAS (tRNAs) | SWITZER, JULIET CAROLINE | — |
| 18964836 | SANITATION METHOD AND SYSTEM | CHORBAJI, MONZER R | — |
| 18853928 | SYSTEMS AND METHODS FOR CONDUCTING REMOTE NEURO-OPHTHALMIC EXAMINATIONS ON A MOBILE DEVICE | BALAJI, KAVYA SHOBANA | — |
| 18892956 | DYNAMIC WALL FOR AUGMENTED REALITY | SANZ, GABRIEL A | — |
| 18655854 | COMPOSITION AND METHOD FOR MUSCLE REPAIR AND REGENERATION | LEE, ANDREW P | — |
| 18593283 | ANGLE-ADJUSTABLE RATCHET TOOL | CHUKWURAH, NATHANIEL C | — |
| Art Unit | Apps |
|---|---|
| 3798 | 2 |
| 1622 | 2 |
| 1636 | 2 |
| 1682 | 1 |
| 1691 | 1 |
| 3723 | 1 |
| 3791 | 1 |
| 1629 | 1 |
| 1654 | 1 |
| 1672 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18982106 | COMPOSITIONS AND METHODS OF USING HisGTG TRANSFER RNAS (tRNAs) | SWITZER, JULIET CAROLINE | 1682 | §101§102§103§112DP | Non-Final OA | — | Pending | Dec 16, 2024 |
| 18964836 | SANITATION METHOD AND SYSTEM | CHORBAJI, MONZER R | — | §102 | Non-Final OA | — | Pending | Dec 02, 2024 |
| 18853928 | SYSTEMS AND METHODS FOR CONDUCTING REMOTE NEURO-OPHTHALMIC EXAMINATIONS ON A MOBILE DEVICE | BALAJI, KAVYA SHOBANA | — | §102§103§112 | Non-Final OA | — | Pending | Oct 03, 2024 |
| 18892956 | DYNAMIC WALL FOR AUGMENTED REALITY | SANZ, GABRIEL A | — | §103 | Non-Final OA | — | Pending | Sep 23, 2024 |
| 18745131 | SYSTEM AND METHOD FOR BREAST CANCER DETECTION USING CO-LOCALIZED ULTRASOUND-MAMMOGRAPHY | FERNANDEZ, KATHERINE L | 3798 | §103§112 | Final Rejection | 14d | Pending | Jun 17, 2024 |
| 18655854 | COMPOSITION AND METHOD FOR MUSCLE REPAIR AND REGENERATION | LEE, ANDREW P | 1691 | §102§103 | Non-Final OA | — | Pending | May 06, 2024 |
| 18706936 | SYSTEMS, DEVICES, AND ASSOCIATED METHODS FOR THERAPEUTIC EUS ANCHOR | FRITH, SEAN A | 3798 | §103 | Non-Final OA | 49d overdue | Pending | May 02, 2024 |
| 18692064 | COMPOSITION FOR TREATING, PREVENTING, OR AMELIORATING MELANOMA AND METHOD THEREOF | DEKARSKE, MADELINE MCGUIRE | 1622 | §103 | Non-Final OA | — | Pending | Mar 14, 2024 |
| 18593283 | ANGLE-ADJUSTABLE RATCHET TOOL | CHUKWURAH, NATHANIEL C | 3723 | §103 | Non-Final OA | — | Pending | Mar 01, 2024 |
| 18443564 | DEVICE AND METHOD FOR ENGAGING A ZIPPER | MELIKA, ERMIA EMAD | — | §102§103§112 | Non-Final OA | — | Pending | Feb 16, 2024 |
| 18427042 | METHOD OF USING PACAP AND VIP PEPTIDES FOR DETECTING SHED OR CIRCULATING TUMOR CELLS IN BIOLOGICAL FLUIDS | LU, CHENG | — | §101§112DP | Non-Final OA | — | Pending | Jan 30, 2024 |
| 18510470 | CORTICAL RECORDING AND SIGNAL PROCESSING METHODS AND DEVICES | OGLES, MATTHEW ERIC | 3791 | §101§112 | Final Rejection | 74d overdue | Pending | Nov 15, 2023 |
| 18482497 | BETA-2 ADRENORECEPTOR MODULATORS AND METHODS OF USING SAME | SEITZ, ANTHONY JOSEPH | 1629 | §102§112 | Non-Final OA | — | Pending | Oct 06, 2023 |
| 18272154 | TYPE I MEMBRANE PROTEINS HETERODIMERS AND METHODS OF USE THEREOF | D' AMBROSIO, THEA | 1654 | §103§112 | Final Rejection | — | Pending | Jul 13, 2023 |
| 18254027 | TRNA FRAGMENTS AND METHODS OF USE | YU, DELPHINUS DOU YI | 1636 | §101§102§112 | Non-Final OA | — | Pending | May 23, 2023 |
| 18034720 | GENE SHUFFLED LYSSAVIRUS VACCINE | CHEN, STACY BROWN | 1672 | §102§112 | Final Rejection | 61d | Pending | May 01, 2023 |
| 18029422 | MEDICAL PORT PROTECTION ADAPTERS | RADOMSKI, MARTIN ADAM | 3783 | §102§103§112 | Final Rejection | — | Pending | Mar 30, 2023 |
| 18065736 | MEASURING FREQUENCY OF PATHOGEN-SPECIFIC T CELLS IN PERIPHERAL BLOOD | GAO, ASHLEY HARTMAN | 1678 | §103§112Other | Final Rejection | 22d | Pending | Dec 14, 2022 |
| 17938428 | COMPOSITIONS AND METHODS OF USING TRANSFER RNAS (tRNAS) | BOESEN, CHRISTIAN C | 1684 | §101§112 | Non-Final OA | — | Pending | Oct 06, 2022 |
| 17637004 | METHODS FOR ENHANCING DNA DAMAGE AND APOPTOSIS OF LEUKEMIC CELLS | SIMMONS, CHRIS E | 1622 | §112 | Non-Final OA | — | Pending | Feb 21, 2022 |
| 17626185 | HETERODIMERS AND METHODS OF USE THEREOF | LU, CHENG | 1642 | §112 | Non-Final OA | — | Pending | Jan 11, 2022 |
| 17599023 | METHODS FOR TREATING CANCERS USING ANTISENSE | PERSONS, JENNA L | 1637 | §103§112DP | Final Rejection | — | Pending | Sep 28, 2021 |
| 15733794 | NONWOVEN HEMP HURD-BASED MATERIALS | SINGH-PANDEY, ARTI R | 1759 | DP | Final Rejection | 50d overdue | Pending | Sep 23, 2021 |
| 17378274 | HUMAN MIRNAS FOR USE IN DIAGNOSIS, PROGNOSIS, AND THERAPY OF HUMAN CONDITIONS AND DISEASES | DACE DENITO, ALEXANDRA GERALDINE | 1636 | §101§103§112 | Final Rejection | 84d overdue | Pending | Jul 16, 2021 |
| 17290797 | METHODS AND COMPOSITIONS FOR TREATING HEPATOCELLULAR CARCINOMA USING ANTISENSE | VAN DRUFF, SYDNEY | 1643 | §103DP | Final Rejection | 6d | Pending | May 03, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial